Covid-19 has forced an unprecedented level of engagement between the public and private sectors but how does that change the traditional ways in which private capital flows in global health?
Now more than ever, essential health services and goods are delivered and supported by the private sector alongside the public sector; from health infrastructure and health care, to medical insurance, pharmaceuticals and beyond. The roles of companies and investors, across industries, have evolved when it comes to health funding conversations as they integrate impact as well-being donors.
In 2020, investors including donors and impact investors are estimated to have contributed $54.8 billion into the global health sector (Institute for Health Metrics and Evaluation), approximately 36% greater than the year before. Understandably, the priority in recent times has been in favor of necessary emergency health coverage.
Whilst the private sector’s role in health continues to increase, health inequities around the world also continue to grow. That leaves an opportunity and imperative to review viable investment opportunities in financing inclusive health in the longer term, building sustainable societies supporting people’s healthy lives.
outside the health industry can play.
- COVID has made health everyone’s business, whereas previously, predominantly health industries only would have seen global health investment as a priority, now it is a priority for multiple businesses
- Huge levels of engagement don’t necessarily mean huge levels of correct or useful investment
- Fatigue amongst corporates of engaging in healthcare initiatives since covid – the feeling of we’ve done enough and want to move on/focus on other areas
- What makes global investment worthwhile and what return on investment can look like?
- What opportunities are there with technology and AI in terms of investing in global health, considering opportunities for tech companies and those with innovative solutions to invest through products/infostructure solutions?
